Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
Times cited: 7
- Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201). PLoS ONE. 2014 Academic Article GET IT
Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: Final 48-week clinical and virologic outcomes.
Journal of Infectious Diseases.
Times cited: 49
Potential risks and benefits of HIV treatment simplification: A simulation model of a proposed clinical trial.
Clinical Infectious Diseases.
Times cited: 17